HomeSVA • TSE
add
Sernova Biotherapeutics Inc
Previous close
$0.17
Day range
$0.17 - $0.17
Year range
$0.15 - $0.39
Market cap
54.20M CAD
Avg Volume
162.62K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.33M | -55.84% |
Net income | -3.78M | 62.01% |
Net profit margin | — | — |
Earnings per share | -0.01 | 66.67% |
EBITDA | -4.28M | 56.16% |
Effective tax rate | -0.99% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.00M | -76.44% |
Total assets | 3.87M | -67.08% |
Total liabilities | 24.53M | 42.07% |
Total equity | -20.66M | — |
Shares outstanding | 328.48M | — |
Price to book | -2.83 | — |
Return on assets | -311.18% | — |
Return on capital | 64.95% | — |
Cash Flow
Net change in cash
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -3.78M | 62.01% |
Cash from operations | -3.84M | 46.99% |
Cash from investing | — | — |
Cash from financing | 4.63M | 2,675.03% |
Net change in cash | 790.14K | 125.72% |
Free cash flow | -3.52M | -8.00% |
About
Founded
2006
Headquarters
Website
Employees
17
